Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 100, Issue 5, Pages 395-402
Publisher
Wiley
Online
2018-01-23
DOI
10.1111/ejh.13030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
- (2017) Simona Piemontese et al. Journal of Hematology & Oncology
- The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group
- (2016) Chang-Lin Yu et al. ANNALS OF HEMATOLOGY
- Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
- (2016) Ivan S. Moiseev et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies
- (2016) Melissa Baker et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
- (2016) M. Mielcarek et al. BLOOD
- Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
- (2016) A Rashidi et al. BONE MARROW TRANSPLANTATION
- Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis
- (2016) P V O'Donnell et al. BONE MARROW TRANSPLANTATION
- Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
- (2016) Rohtesh S. Mehta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
- (2016) Sameh Gaballa et al. CANCER
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
- (2016) Sarah Morin-Zorman et al. Frontiers in Immunology
- Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease
- (2015) Kenneth F. Bradstock et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
- (2015) Nicoletta Cieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
- (2015) S. G. Holtan et al. BLOOD
- PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression
- (2015) Maria Kohl et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation
- (2015) Udo Holtick et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide
- (2014) Luca Castagna et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD
- (2014) I. F. Khouri et al. BLOOD
- Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
- (2014) P. Armand et al. BLOOD
- Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen
- (2014) P D Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice
- (2013) T Ruutu et al. BONE MARROW TRANSPLANTATION
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
- (2012) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
- (2012) Scott R. Solomon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
- (2012) Anna Maria Raiola et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation
- (2012) T Ruutu et al. BONE MARROW TRANSPLANTATION
- Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre
- (2012) I. A. Bilmon et al. INTERNAL MEDICINE JOURNAL
- Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation
- (2011) Ron Ram et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation
- (2011) Dai-Hong Liu et al. PEDIATRIC BLOOD & CANCER
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2010) Byung-Sik Cho et al. TRANSPLANTATION
- Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia
- (2009) C. Craddock et al. HAEMATOLOGICA
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started